Rwc Asset Management LLP has filed its 13F form on August 13, 2025 for Q2 2025 where it was disclosed a total value porftolio of $1.52 Billion distributed in 172 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Hp Inc with a value of $141M, Macy'S, Inc. with a value of $124M, Exelon Corp with a value of $80.5M, Cisco Systems, Inc. with a value of $56.8M, and Constellation Energy Corp with a value of $53M.
Examining the 13F form we can see an decrease of $24M in the current position value, from $1.55B to 1.52B .
Rwc Asset Management LLP is based out at London, X0
Below you can find more details about Rwc Asset Management LLP portfolio as well as his latest detailed transactions.
Portfolio value
$1.52 Billion
Utilities: $390 Million
Consumer Cyclical: $244 Million
Technology: $234 Million
Consumer Defensive: $227 Million
Real Estate: $89.4 Million
Industrials: $68.5 Million
Healthcare: $66.1 Million
Basic Materials: $64.9 Million
Other: $138 Million
Stock
Market Cap.
Holding Value (Reported)
# of Shares.
Last Trade
Trade History
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 34.78%
-
$0
0.0% of portfolio
-
Q2 2025
Added 100.0%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 11.11%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 41.67%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q1 2024
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 3.23%
-
$0
0.0% of portfolio
-
Q2 2025
Added 70.73%
-
$0
0.0% of portfolio
-
Q2 2025
Added 7.14%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 23.33%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 25.0%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 5.88%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 32.0%
American Airlines Group Inc
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 25.64%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 37.45%
-
$0
0.0% of portfolio
-
Q2 2025
Added 19.76%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 15.63%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 69.57%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 45.45%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 24.73%
-
$0
0.0% of portfolio
-
Q2 2025
New
Vishay Intertechnology Inc
-
$0
0.0% of portfolio
-
Q2 2025
Added 10.0%
Alnylam Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 34.15%
Ventas Rlty LTD Partnership
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 8.33%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 22.37%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 34.25%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 27.03%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 8.0%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 14.29%
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 21.74%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 25.86%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 15.38%
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q3 2023
Added 67.33%
-
$0
0.0% of portfolio
-
Q2 2025
New
Ionis Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 18.92%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 21.74%
Halozyme Therapeutics Inc
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 8.57%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 30.0%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2024
New